Beneficient (BENF) Non Operating Interest Expenses (2021 - 2026)
Beneficient's (BENF) quarterly Non Operating Interest Expenses came in at $1.7 million in Q2 2026, down 33.4% year-over-year from $2.5 million in Q2 2025, and down 8.9% quarter-over-quarter from $1.8 million in Q1 2026.
Analysis
Beneficient (BENF) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends
Beneficient has disclosed Non Operating Interest Expenses across 6 years of filings, most recently posting $1.7 million for Q2 2026.
- In Q2 2026, Non Operating Interest Expenses fell 33.4% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $7.9 million (down 28.0% YoY), while the FY2026 annual figure was $8.7 million, down 24.47% from the prior year.
- Non Operating Interest Expenses came in at $1.7 million for Q2 2026 at Beneficient, down from $1.8 million in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $13.8 million in Q3 2022 to a low of $1.7 million in Q2 2026.
- Average Non Operating Interest Expenses over 5 years is $4.3 million, with a median of $3.0 million recorded in 2025.
- The largest YoY upside for Non Operating Interest Expenses was 1.89% in 2023 against a maximum downside of 62.68% in 2023.
- Over 5 years, Non Operating Interest Expenses stood at $13.8 million in 2022, then tumbled by 60.06% to $5.5 million in 2023, then plunged by 51.38% to $2.7 million in 2024, then retreated by 27.13% to $2.0 million in 2025, then retreated by 15.05% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $1.7 million in Q2 2026, $1.8 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn | 281.69 Mn |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - | 93.62 Mn |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn | 10.01 Mn |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn | -3.22 Mn |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn | 73.91 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn | 123.43 Mn |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - | 30.37 Mn |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn | 25.52 Mn |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - | -18.74 Mn |
| 10 | Beneficient | 34.48 Mn | 119.41 Mn | - | 1.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.79 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 4.25 Mn |
| Dec 31, 2023 | 5.51 Mn |
| Sep 30, 2023 | 5.15 Mn |
| Jun 30, 2023 | 6.94 Mn |
| Sep 30, 2022 | 13.80 Mn |
| Jun 30, 2022 | 7.08 Mn |
| Mar 31, 2021 | 7.18 Mn |